Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cardioprotection in cancer therapy: novel insights with anthracyclines
Inbar Raber, Aarti Asnani
Cardiovascular Research (2019) Vol. 115, Iss. 5, pp. 915-921
Closed Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Cardiovascular Toxicity Related to Cancer Treatment: A Pragmatic Approach to the American and European Cardio‐Oncology Guidelines
Joachim Alexandre, Jennifer Cautela, Stéphane Éderhy, et al.
Journal of the American Heart Association (2020) Vol. 9, Iss. 18
Open Access | Times Cited: 236
Red emission carbon dots for mitoxantrone detection
Yujia Zhong, Anli Chen, Xinghang Yin, et al.
Sensors and Actuators B Chemical (2023) Vol. 382, pp. 133535-133535
Closed Access | Times Cited: 42
Protosappanin A Protects DOX‐Induced Myocardial Injury and Cardiac Dysfunction by Targeting ACSL4/FTH1 Axis‐Dependent Ferroptosis
Jingxuan Cui, Yujia Chen, Qiannan Yang, et al.
Advanced Science (2024)
Open Access | Times Cited: 20
Progress in cardiac research: from rebooting cardiac regeneration to a complete cell atlas of the heart
Sean M. Davidson, Teresa Padró, Sveva Bollini, et al.
Cardiovascular Research (2021) Vol. 117, Iss. 10, pp. 2161-2174
Open Access | Times Cited: 41
Cancer Treatment-Associated Pericardial Disease: Epidemiology, Clinical Presentation, Diagnosis, and Management
K. Sarat Chandra, Allan L. Klein, Javid J. Moslehi
Current Cardiology Reports (2019) Vol. 21, Iss. 12
Closed Access | Times Cited: 43
Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells
Rui Liu, Dong Li, Fangxu Sun, et al.
Stem Cell Research & Therapy (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 24
Cancer treatment-related cardiovascular disease: Current status and future research priorities
Miki Nonaka, Hiroshi Hosoda, Yasuhito Uezono
Biochemical Pharmacology (2021) Vol. 190, pp. 114599-114599
Closed Access | Times Cited: 20
Introduction to cancer and treatment approaches
Madihalli Somashekharaiah Chandraprasad, Abhijit Dey, Mallappa Kumara Swamy
Elsevier eBooks (2021), pp. 1-27
Closed Access | Times Cited: 19
5-Hydroxytryptophan acts as a gap junction inhibitor to limit the spread of chemotherapy-induced cardiomyocyte injury and mitochondrial dysfunction
Wenshe Sun, Qi Lu, Yukun Zhang, et al.
Aging (2024)
Open Access | Times Cited: 2
Cardio-oncology: a novel platform for basic and translational cardiovascular investigation driven by clinical need
Javid J. Moslehi, Keigi Fujiwara, Tomasz J. Guzik
Cardiovascular Research (2019) Vol. 115, Iss. 5, pp. 819-823
Closed Access | Times Cited: 21
Cancer Therapeutics-Related Cardiac Dysfunction ― Insights From Bench and Bedside of Onco-Cardiology ―
Hiroshi Kadowaki, Hiroshi Akazawa, Junichi Ishida, et al.
Circulation Journal (2020) Vol. 84, Iss. 9, pp. 1446-1453
Open Access | Times Cited: 16
Encapsulation and Release of Doxorubicin from TiO2Nanotubes: Experiment, Density Functional Theory Calculations, and Molecular Dynamics Simulation
Sadaf Shirazi-Fard, Fatemeh Mohammadpour, Amin Reza Zolghadr, et al.
The Journal of Physical Chemistry B (2021) Vol. 125, Iss. 21, pp. 5549-5558
Closed Access | Times Cited: 14
Plasma biomarkers reflecting high oxidative stress in the prediction of myocardial injury due to anthracycline chemotherapy and the effect of carvedilol: insights from the CECCY Trial
Mauro Rogério de Barros Wanderley, Mônica Samuel Ávila, Miguel Morita Fernandes-Silva, et al.
Oncotarget (2022) Vol. 13, Iss. 1, pp. 214-223
Open Access | Times Cited: 9
Characteristics and research status among clinical trials in cardio‐oncology by bibliometric and visualized analysis
Liu Lini, Rong Xu, Wei Huang, et al.
Cancer Medicine (2023) Vol. 12, Iss. 11, pp. 12535-12547
Open Access | Times Cited: 5
How to Treat Diffuse Large B-Cell Lymphoma
Swetha Kambhampati Thiruvengadam, Alex F. Herrera, June‐Wha Rhee
JACC CardioOncology (2023) Vol. 5, Iss. 3, pp. 281-291
Open Access | Times Cited: 4
A CircRNA–miRNA–mRNA Network for Exploring Doxorubicin- and Myocet-Induced Cardiotoxicity in a Translational Porcine Model
Julia Mester-Tonczar, Patrick Einzinger, Ena Hašimbegović, et al.
Biomolecules (2023) Vol. 13, Iss. 12, pp. 1711-1711
Open Access | Times Cited: 4
Knock-down of FOXO3, GATA2, NFE2L2 and AHR promotes doxorubicin-induced cardiotoxicity in human cardiomyocytes.
J.G. Faber, J. Ochoteco Asensio, F. Caiment, et al.
Toxicology (2024) Vol. 509, pp. 153977-153977
Open Access | Times Cited: 1
Real-life incidence of cardiotoxicity and associated risk factors in sarcoma patients receiving doxorubicin
Joanna Vitfell-Rasmussen, Anders Krarup‐Hansen, Merete Vaage‐Nilsen, et al.
Acta Oncologica (2022) Vol. 61, Iss. 7, pp. 801-808
Closed Access | Times Cited: 7
Predictors of new-onset heart failure and overall survival in metastatic breast cancer patients treated with liposomal doxorubicin
Sebastian Szmit, Aleksandra Grela-Wojewoda, Małgorzata Talerczyk, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 9
The Spatial Ventricular Gradient Is an Independent Predictor of Anthracycline-Associated Cardiotoxicity
Andrea Nathalie Rosas Diaz, Hans F. Stabenau, Gabriel Pajares Hurtado, et al.
JACC Advances (2023) Vol. 2, Iss. 2, pp. 100269-100269
Open Access | Times Cited: 3
Early Predictive Value of NT-proBNP Combined With Echocardiography in Anthracyclines Induced Cardiotoxicity
Yingjun Dong, Qiong Wu, Changqing Hu
Frontiers in Surgery (2022) Vol. 9
Open Access | Times Cited: 5
Cardiovascular Toxicity of Antineoplastic Treatments in Hematological Diseases: Focus on Molecular Mechanisms to Improve Therapeutic Management
Serena Barachini, Gabriele Buda, Iacopo Petrini
Journal of Clinical Medicine (2024) Vol. 13, Iss. 6, pp. 1574-1574
Open Access
Detection and interpretation of clonal hematopoiesis variants during routine solid tumor next-generation sequencing: a single institution experience
Adil Menon, Madina Sukhanova, Kevin L Nocito, et al.
Journal of Molecular Diagnostics (2024) Vol. 26, Iss. 12, pp. 1149-1158
Open Access
4) Basic Research and Future Developments in Onco-cardiology
Yasushi Sakata
Nihon Naika Gakkai Zasshi (2023) Vol. 112, Iss. 9, pp. 1588-1593
Open Access
The Current Status and Future Perspective of Cardio-Oncology
Hiroshi Kadowaki, Junichi Ishida, Hiroshi Akazawa
Nihon Naika Gakkai Zasshi (2020) Vol. 109, Iss. 4, pp. 819-826
Open Access
Page 1 - Next Page

Scroll to top